Anhydrovinblastine

Star0

DB12586InvestigationalSmall molecule

Anhydrovinblastine has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Formula / weight: C₄₆H₅₆N₄O₈ · 792.974 g/mol (avg)
Code names: F-81097

Resolves to

Compound

UNII5B622U08B3CAS38390-45-3PubChem11104750

Structure

InChIKeyFFRFGVHNKJYNOV-ZCIMLLHDSA-NSMILES

CCC1=C[C@@H]2C[N@](C1)CCC1=C(NC3=CC=CC=C13)[C@@](C2)(C(=O)OC)C1=CC2=C(C=C1OC)N(C)[C@@H]1[C@]22CCN3CC=C[C@](CC)([C@@H]23)[C@@H](OC(C)=O)[C@]1(O)C(=O)OC

What you can answer from here — as of June 12, 2020

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of Anhydrovinblastine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account